Zoledronic acid inhibits primary bone tumor growth in Ewing sarcoma. [electronic resource]
Producer: 20060112Description: 1713-20 p. digitalISSN:- 0008-543X
- Animals
- Antineoplastic Agents, Phytogenic -- therapeutic use
- Apoptosis -- drug effects
- Bone Density Conservation Agents -- therapeutic use
- Bone Neoplasms -- diagnostic imaging
- Cell Proliferation -- drug effects
- Diphosphonates -- therapeutic use
- Drug Therapy, Combination
- Enzyme-Linked Immunosorbent Assay
- Glycoproteins -- metabolism
- Humans
- Imidazoles -- therapeutic use
- Immunoenzyme Techniques
- Mice
- Mice, Nude
- Osteoclasts -- cytology
- Osteoprotegerin
- Paclitaxel -- therapeutic use
- Radiography
- Receptors, Cytoplasmic and Nuclear -- metabolism
- Receptors, Tumor Necrosis Factor -- metabolism
- Reverse Transcriptase Polymerase Chain Reaction
- Sarcoma, Ewing -- diagnostic imaging
- Zoledronic Acid
No physical items for this record
Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.